Femoral intra-arterial injection: A tool to deliver and assess recombinant AAV constructs in rodents whole hind limb

Journal of Gene Medicine

Volumn 7, Issue 6, 2005, Pages 782-791

  Gonin, Patrick ^a   Arandel, Ludovic ^a   Van Wittenberghe, Laetitia ^a   Marais, Thibaut ^a   Perez, Norma ^a   Danos, Olivier ^a  

^a CNRS   (France)

Author keywords

Adeno associated virus; Drug delivery; Gene therapy; Intra vascular; Pharmacology

Indexed keywords

ALKALINE PHOSPHATASE; DYSTROPHIN; PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMORAL ARTERY; GENE TRANSFER; GENETIC TRANSDUCTION; HINDLIMB; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; RECTUS FEMORIS MUSCLE; REPORTER GENE; SEROTYPE; SOLEUS MUSCLE; STAINING; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

ALKALINE PHOSPHATASE; ANIMALS; CYTOMEGALOVIRUS; DEPENDOVIRUS; FEMUR; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; INJECTIONS, INTRA-ARTERIAL; KINETICS; LOWER EXTREMITY; LUCIFERASES; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUSCLE, SKELETAL; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SEROTYPING; TRANSDUCTION, GENETIC; TRANSGENES;

ADENO-ASSOCIATED VIRUS; CUCUMBER MOSAIC VIRUS; MURINAE; RECTUS; RODENTIA;

EID: 21044441685     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.716     Document Type: Article

References (28)

1. Somiari S, Glasspool-Malone J, Drabick J, et al. Theory and in vivo application of electroporative gene delivery. Mol Ther 2000; 2: 178-187.
2. Yamashita Y, Shimada M, Tachibana K, et al. In vivo gene transfer into muscle via electro-sonoporation. Hum Gene Ther 2002; 13: 2079-2084.
3. Budker V, Zhang G, Danko I, et al. The efficient expression of intravascularly delivered DNA in rat muscle. Gene Ther 1998; 5: 272-276.
4. Greelish J, Su L, Lankford E, et al. Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector. Nat Med 1999; 5: 439-443.
5. Xiao X, Li J, Samulski R. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 1998; 72: 2224-2232.
6. Chao H, Liu Y, Rabinowitz J, et al. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol Ther 2000; 2: 619-623.
7. Wang M, Orsini C, Casanova D, et al. MUSEAP, a novel reporter gene for the study of long-term gene expression in immunocompetent mice. Gene 2001; 279: 99-108.
8. Fabb S, Wells D, Serpente P, et al. Adeno-associated virus vector gene transfer and sarcolemmal expression of a 144 kDa microdystrophin effectively restores the dystrophin-associated protein complex and inhibits myofibre degeneration in nude/mdx mice. Hum Mol Genet 2002; 11: 733-741.
9. Li X, Eastman E, Schwartz R, et al. Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences. Nat Biotechnol 1999; 17: 241-245.
10. Goyenvalle A, Vulin A, Fougerousse F, et al. Highly efficient exon-skipping and sustained correction of muscular dystrophy using an adeno-associated viral vector. 2004; submitted.
11. Hauser M, Robinson A, Hartigan-O'Connor D, et al. Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors. Mol Ther 2000; 2: 16-25.
12. Bulfield G, Siller W, Wight P, et al. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A 1984; 81: 1189-1192.
13. Chapman V, Miller D, Armstrong D, et al. Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice. Proc Natl Acad Sci U S A 1989; 86: 1292-1296.
14. Waldrop F, Puchtler H. Kernechtrot: a convenient nuclear stain after ferro- or ferricyanide reactions. Stain Technol 1977; 52: 237.
15. Xiao W, Chirmule N, Berta S, et al. Gene therapy vectors based on adeno-associated virus type 1. J Virol 1999; 73: 3994-4003.
16. Hauck B, Xiao W. Characterization of tissue tropism determinants of adeno-associated virus type 1. J Virol 2003; 77: 2768-2774.
17. Staron R, Kraemer W, Hikida R, et al. Fiber type composition of four hindlimb muscles of adult Fisher 344 rats. Histochem Cell Biol 1999; 111: 117-123.
18. Wigston D, English A. Fiber-type proportions in mammalian soleus muscle during postnatal development. J Neurobiol 1992; 23: 61-70.
19. Herweijer H, Wolff J. Progress and prospects: naked DNA gene transfer and therapy. Gene Ther 2003; 10: 453-458.
20. McIntosh D, Tan X, Oh P, et al. Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery. Proc Natl Acad Sci U S A 2002; 99: 1996-2001.
21. Oh P, Li Y, Yu J, et al. Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature 2004; 429: 629-635.
22. Vilquin J, Kennel P, Paturneau-Jouas M, et al. Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies. Gene Ther 2001; 8: 1097-1107.
23. Zhang G, Budker V, Williams P, et al. Surgical procedures for intravascular delivery of plasmid DNA to organs. Methods Enzymol 2002; 346: 125-133.
24. Zhang G, Budker V, Williams P, et al. Efficient expression of naked DNA delivered intraarterially to limb muscles of nonhuman primates. Hum Gene Ther 2001; 12: 427-438.
25. Liang K, Nishikawa M, Liu F, et al. Restoration of dystrophin expression in mdx mice by intravascular injection of naked DNA containing full-length dystrophin cDNA. Gene Ther 2004; 11: 901-908.
26. Hagstrom J, Hegge J, Zhang G, et al. A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs. Mol Ther 2004; 10: 386-398.
27. Gregorevic P, Blankinship M, Allen J, et al. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med 2004; 10: 828-834.
28. Wells D. Opening the floodgates: clinically applicable hydrodynamic delivery of plasmid DNA to skeletal muscle. Mol Ther 2004; 10: 207-208.